WHO chief scientist, vaccine makers to address BioAsia

To be held virtually from Feb. 24

Published - February 10, 2022 11:05 pm IST - HYDERABAD

Well-known scientists, policy makers and top leadership of major vaccine manufacturers are scheduled to address the 19th edition of BioAsia, a two-day life sciences and healthcare forum that will be held virtually from February 24.

The panel discussion will feature pioneers, innovators and leaders, including World Health Organisation’s Chief Scientist Dr. Soumya Swaminathan; Director, EU Chief Scientific Advisor Epidemics Peter Piot; and NITI Aayog CEO Amitabh Kant, organisers of the Telangana government’s flagship biotechnology event said in a release on Thursday.

The 2022 edition of BioAsia seeks to deliberate on the pandemic, learnings, progress made so far and discuss the future of healthcare to support and enable global collective recovery to pivot beyond the pandemic. The panel discussion on “Two years into the pandemic” will focus on streamlining the healthcare delivery system and highlighting equitable access to healthcare for growth. It will also focus on how vaccine development and manufacturing can be accelerated.

Others scheduled to address BioAsia include Public Health Foundation of India president Dr. K. Srinath Reddy; microbiologist and virologist Gagandeep Kang; Bharat Biotech CMD Krishna Ella, Biological E. MD Mahima Datla and Secretary to the Centre’s Department of Biotechnology Rajesh S. Gokhale.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in


Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.